Previously overlooked protein helps cells divide correctly
Modern technologies have made it possible to uncover a growing "hidden proteome"—proteins encoded by parts of the genome that researchers previously overlooked.
Key points
- Focus: Modern technologies have made it possible to uncover a growing "hidden proteome"—proteins encoded by parts of the genome that researchers previously
- Detail: Science reporting: verify primary technical documentation
- Editorial reading: science reporting; whenever possible, verify the cited primary source.
Modern technologies have made it possible to uncover a growing "hidden proteome"—proteins encoded by parts of the genome that researchers previously overlooked. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.
It is relevant because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: Add as preferred source Microscope images showing different stages of cell division.
Sagar Mahale Modern technologies have made it possible to uncover a growing "hidden proteome"—proteins encoded by parts of the genome that researchers previously overlooked. Sagar Mahale, a researcher at Sahlgrenska Academy at the University of Gothenburg and first author of both studies, says, "What is particularly interesting is that the RNA.
They act through different pathways in the cell, but both help maintain the same essential structure when the cell divides. When the researchers reduced the amount of RNA or disrupted MSEP production in cultured cervical cancer cells, the cells showed reduced growth and proliferation.
But it is too early to say whether the protein could become a target for future treatments. " The findings are based on studies of cultured cells. Sagar Mahale et al, A bifunctional ARHGEF17-AS1 locus encodes MSEP, a protein that supports mitotic spindle organization, Cell Reports (2026).
The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.
Sagar Mahale et al, The spindle-associated antisense RNA ARHGEF17-AS1 functionally contributes to mitotic spindle integrity, Cell Reports (2026). MA in English, copy editor since 2021 with experience in higher education and health content.
Because this item comes through Phys. org Biology as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.
The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Original source: Phys. org Biology